02496.HK
Wuhan YZY Biopharma Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.30
−8.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -10.31x
- Price / sales
- 6.45x
- Price / cash flow
- -13.68x
Enterprise value
- Enterprise value
- HKD 672.1M
- EV / sales
- 6.78x
- EV / EBITDA
- -6.44x
- EV / EBIT
- -5.80x
- Market cap
- HKD 639.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025